REFR RESEARCH FRONTIERS INC
Patent Owners & Lessors · Nasdaq · SEC CIK 793524 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-69.7%
TTM net income YoY-30.4%
TTM EPS YoY-16.7%
Revenue 3-yr CAGR-20.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-670.2%
Net margin-662.0%
FCF margin-500.4%
EBITDA margin-669.3%
Returns
ROE-233.1%
ROA-104.1%
ROIC (approx.)-1,167.3%
Asset turnover0.16x
Leverage & solvency
Liabilities / assets68.7%
Debt / equity0.00x
Current ratio2.21x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.76x
Accruals ratio-25.4%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.12M | $1.34M | $909,598 | $539,686 | $1.26M |
| R&D expense | $608,732 | $570,007 | $583,266 | $609,127 | $580,000 |
| Operating income | -$2.13M | -$1.44M | -$2.03M | -$2.63M | -$1.84M |
| Net income | -$2.05M | -$1.31M | -$1.91M | -$2.67M | -$1.85M |
| EBITDA | -$2.12M | -$1.43M | -$2.02M | -$2.60M | -$1.81M |
| EPS (basic) | -0.06 | -0.04 | -0.06 | -0.08 | -0.06 |
| EPS (diluted) | -0.06 | -0.04 | -0.06 | -0.08 | -0.06 |
| Weighted avg. shares (diluted) | 33.65M | 33.52M | 33.45M | 32.07M | 31.65M |
| Balance sheet | |||||
| Cash & equivalents | $664,299 | $1.99M | $2.48M | $4.23M | $269,964 |
| Short-term investments | — | — | — | — | $2.76M |
| Receivables | $408,666 | $658,213 | $1.00M | $589,599 | — |
| Current assets | $1.14M | $2.75M | $3.58M | $4.92M | $3.95M |
| PP&E, net | $3,393 | $15,052 | $39,598 | $65,388 | $92,954 |
| Total assets | $2.25M | $4.04M | $3.85M | $5.37M | $4.55M |
| Current liabilities | $297,877 | $269,027 | $277,431 | $301,863 | $297,936 |
| Total liabilities | $1.32M | $1.44M | $332,794 | $569,586 | $762,064 |
| Shareholders' equity | $933,626 | $2.60M | $3.52M | $4.80M | $3.78M |
| Shares outstanding | 33.65M | 33.65M | 33.51M | 33.15M | 31.65M |
| Cash flow statement | |||||
| Operating cash flow | -$1.33M | -$788,819 | -$2.30M | -$2.18M | -$1.80M |
| Capital expenditure | $726 | $1,623 | $1,558 | $1,271 | $1,077 |
| Free cash flow | -$1.33M | -$790,442 | -$2.30M | -$2.18M | -$1.81M |
| Investing cash flow | -$726 | -$1,623 | $55,591 | $2.69M | -$2.78M |
| Financing cash flow | — | $308,670 | $484,502 | $3.45M | $86,262 |
| Depreciation & amortization | $11,478 | $14,978 | $14,745 | $28,837 | $29,895 |
| Stock-based compensation | $374,875 | $89,316 | $144,728 | $232,291 | $217,008 |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.